Biology, asked by sujal5566, 1 year ago

Brodalumab mechanism of action in psoriasis

Answers

Answered by laxmipriyaojha2002
0

Mechanism of action. Brodalumab binds to the interleukin-17 receptor and so prevents interleukin 17 (IL-17) from activating the receptor. (This mechanism is similar to that of another anti-psoriasis antibody, ixekizumab, which however binds to IL-17 itself.)

Answered by TheHoneyBabe
0

Explanation:

Psoriasis is thought to be an immune system problem. Triggers include infections, stress and cold.

Similar questions